Childhood Cancer

You are here

Home » Grants » All grants tagged with "Rhabdomyosarcoma"

All grants tagged with "Rhabdomyosarcoma"

Synthetic gene expression regulator switches (SynGERS) expressed in CAR T cells to cure children with solid tumors
Andras Heczey, MD
Baylor College of Medicine
R Accelerated Award Grants, Awarded 2023
Development of New Approaches to Target MAP Kinase Pathway in RAS-driven Rhabdomyosarcoma
Angelina Vaseva, PhD
University of Texas Health Science Center at San Antonio
R Accelerated Award Grants, Awarded 2023
Unraveling the Function of PAX3-FOXO1’s Activation Domain in Rhabdomyosarcoma
Berkley Gryder, PhD
Case Western Reserve University
'A' Award Grants, Awarded 2023
Genomic and nuclear organizational changes in chemotherapy-resistant rhabdomyosarcoma cells
Kyle MacQuarrie, MD/PhD
Ann & Robert H. Lurie Children’s Hospital of Chicago
'A' Award Grants, Awarded 2023
Targeting Chromatin Remodeling Complexes for Rhabdomyosarcoma (RMS) Therapy
Jun Qi, PhD
Dana-Farber Cancer Institute
Innovation Grants, Awarded 2023
CDK8 as a New Therapeutic Target in Alveolar Rhabdomyosarcoma
Susu Zhang, PhD
Dana-Farber Cancer Institute
Young Investigator Grants, Awarded 2023
Synthetic Gene Expression Regulatory Switches (SynGERS) for Improved CAR T Cell Function in Pediatric Solid Tumors
Leidy Diana Caraballo Galva, PhD
Baylor College of Medicine
Young Investigator Grants, Awarded 2023
A Novel and Rationale Drug Combination in Preclinical Models of Rhabdomyosarcoma
Reima Bash
Duke University
POST Program Grants, Awarded 2023
Therapeutic potential and use of novel CRISPR technology for lncRNA knockdown in rhabdomyosarcoma
Samantha Weitzel
Duke University
POST Program Grants, Awarded 2022
The Rhabdomyoblast Project
Sofia Tosoni
Children’s Cancer Therapy Development Institute
POST Program Grants, Awarded 2022

Pages

All childhood cancer types

Featured Hero

Sam Glossi

At 3-and-a-half years old, Sam's parents found a large lump on Sam's abdomen. He underwent surgery to remove it and was cancer-free for a short time. When the cancer returned, it was treated like stage 4 neuroblastoma. Sam has been cancer-free since 2017!
Read more »